← FDA Drug Approvals (Drugs@FDA)

TRILIPIX

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2008-12-15

Drug application

FDA Application #

NDA022224

Application type

New Drug Application

Brand name

TRILIPIX

Generic name

FENOFIBRIC ACID

Active ingredients

CHOLINE FENOFIBRATE

Dosage form

CAPSULE, DELAYED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

Manufacturer

Amneal Pharmaceuticals of New York LLC

First approval

2008-12-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown